Literature DB >> 12887140

Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation.

Richard A Magill1, William F Waters, George A Bray, Julia Volaufova, Steven R Smith, Harris R Lieberman, Nancy McNevin, Donna H Ryan.   

Abstract

Cognitive and motor performance are critical in many circumstances and are impaired by sleep deprivation. We administered placebo, tyrosine 150 mg/kg, caffeine 300 mg/70 kg, phentermine 37.5 mg and D-amphetamine 20 mg at 15.30 h following overnight sleep deprivation and compare their effects on cognitive and motor performance in healthy young men. Tests of visual scanning, running memory, logical reasoning, mathematical processing, the Stroop task, four-choice serial reaction time, time wall take, pursuit tracking, visual vigilance, Trails (B) task and long-term memory were evaluated at standardized intervals before, during and after sleep deprivation and drugs. Performance decrements with sleep deprivation occurred in visual scanning, running memory, logical reasoning, mathematical processing, the Stroop test, the time wall test, tracking and visual vigilance. Interestingly, with sleep deprivation some tests improved and others did not deteriorate. Improvements with medication following sleep deprivation were seen in running memory, logical reasoning, mathematical processing, tracking and visual vigilance. Although less effective than D-amphetamine, tyrosine improved performance on several tests. We conclude that all drugs tested improved at least some aspects of cognitive and motor performance after sleep deprivation. As a naturally occurring amino acid, and thus amenable to nutritional strategies, tyrosine may deserve further testing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887140     DOI: 10.1080/1028415031000120552

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  19 in total

1.  Effects of d-amphetamine on simulated driving performance before and after sleep deprivation.

Authors:  Magnus Hjälmdahl; Anna Vadeby; Asa Forsman; Carina Fors; Gunnel Ceder; Per Woxler; Robert Kronstrand
Journal:  Psychopharmacology (Berl)       Date:  2012-05-26       Impact factor: 4.530

Review 2.  Vigilance, alertness, or sustained attention: physiological basis and measurement.

Authors:  B S Oken; M C Salinsky; S M Elsas
Journal:  Clin Neurophysiol       Date:  2006-04-03       Impact factor: 3.708

3.  Does acute caffeine ingestion alter brain metabolism in young adults?

Authors:  Feng Xu; Peiying Liu; James J Pekar; Hanzhang Lu
Journal:  Neuroimage       Date:  2015-01-30       Impact factor: 6.556

4.  A meta-analysis of the impact of short-term sleep deprivation on cognitive variables.

Authors:  Julian Lim; David F Dinges
Journal:  Psychol Bull       Date:  2010-05       Impact factor: 17.737

5.  The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance.

Authors:  Beata Y Silber; Rodney J Croft; Katherine Papafotiou; Con Stough
Journal:  Psychopharmacology (Berl)       Date:  2006-06-08       Impact factor: 4.530

6.  Sleep Deprivation and Time-Based Prospective Memory.

Authors:  Maria José Esposito; Miranda Occhionero; PierCarla Cicogna
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

7.  Acute oral administration of a tyrosine and phenylalanine-free amino acid mixture reduces exercise capacity in the heat.

Authors:  Les Tumilty; Glen Davison; Manfred Beckmann; Rhys Thatcher
Journal:  Eur J Appl Physiol       Date:  2013-01-04       Impact factor: 3.078

8.  Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.

Authors:  Sarah A Morrow; Audrey Smerbeck; Kara Patrick; Diane Cookfair; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  J Neurol       Date:  2012-09-23       Impact factor: 4.849

Review 9.  Pharmacological manipulation of human working memory.

Authors:  Deanna M Barch
Journal:  Psychopharmacology (Berl)       Date:  2004-01-30       Impact factor: 4.530

10.  A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults.

Authors:  David H Winslow; Charles H Bowden; Karen P DiDonato; Pamela A McCullough
Journal:  Sleep       Date:  2012-11-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.